Delivery Order 36F79721D0141-36C24526N0673

The Department of Veterans Affairs Veterans Health Administration awarded a $10,868 delivery order against Recordati Rare Diseases, Inc.'s Pharmaceuticals and Drugs GSA Schedule to supply SIGNIFOR LAR 40 MG. The prime contractor will deliver the drug to a facility in Bartlett, Tennessee within the period of performance from October 11-13, 2023. Recordati Rare Diseases, Inc. will perform as the prime contractor under this firm fixed price contract issued by VA-VHA Network 5 to support its...

The U.S. Department of Veterans Affairs (VA) awarded a delivery order contract to Recordati Rare Diseases Inc., a division of the international pharmaceutical company Recordati Group, for the provision of Signifor LAR 40 mg. The order, valued at $10,811.24, is being delivered under Recordati's Federal Supply Schedule (FSS-61-IB) contract with the VA, a five-year, $15.6 million indefinite-delivery vehicle established in April 2021. The contract does not include a set-aside designation, reflecting...

This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Recordati Rare Diseases Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in rare disease treatments. The contract, valued at $11,219.21, is for the supply of Signifor LAR 40 MG, a medication used to treat Cushing's disease. The delivery order was placed under the VA's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs, which allows the VA to efficiently...

Recordati Rare Diseases Inc. was awarded a $22,438.42 firm fixed-price delivery order by Veterans Integrated Service Network 5 (VISN 5) for SIGNIFOR LAR 40 MG, a specialized pharmaceutical treatment for rare endocrine disorders such as Cushing's disease and acromegaly. The delivery order, awarded on December 5, 2025, with an ultimate completion date of December 9, 2025, will be performed in Bartlett, Tennessee. This award carries no set-aside designation and falls under the Pharmaceuticals and...

The Department of Veterans Affairs Veterans Health Administration awarded a $10,793.52 delivery order against Recordati Rare Diseases, Inc.'s Pharmaceuticals and Drugs GSA Schedule contract to supply SIGNIFOR LAR 30 MG. The prime contractor, Recordati Rare Diseases Inc., will deliver the specified pharmaceutical to the VA facility located in Bartlett, Tennessee. The order has a period of performance from December 27, 2023 through December 29, 2023 and utilizes a firm fixed price contract type....

Recordati Rare Diseases Inc. was awarded a delivery order against its Pharmaceuticals and Drugs Federal Supply Schedule contract to provide Signifor LAR 30 mg and 40 mg to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The potential value of this firm fixed price order is $21,623.35 to be performed at a place of performance in Bartlett, Tennessee by January 31, 2024. Recordati holds two key indefinite-delivery vehicles for supplying...

This is a delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Recordati Rare Diseases Inc., a foreign-owned pharmaceutical manufacturer, for the drug Signifor LAR 40 mg. The contract is a firm fixed-price delivery order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has a ceiling value of $44,876.84. The contract will support the delivery of this specialized medication to VA medical facilities through March 2025, providing...

The U.S. Department of Veterans Affairs (VA) awarded a Delivery Order contract worth $10,811.24 to Recordati Rare Diseases Inc., a division of the international pharmaceutical company Recordati Group. The contract is for the supply of Signifor LAR 40 MG, a treatment for Cushing's disease and acromegaly. This award is associated with Recordati's larger, $15.6 million Federal Supply Schedule (FSS-61-IB) contract with the VA, as well as a $3.1 million Blanket Purchase Agreement (BPA) for a range of...

The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price delivery order contract to Recordati Rare Diseases Inc., a division of the Recordati Group, for the pharmaceutical product Signifor LAR 40 mg. The contract has a ceiling value of $10,811.24 and an ultimate completion date of November 22, 2024. This delivery order is placed against Recordati's five-year, $15.6 million Federal Supply Schedule (FSS-61-IB) contract with the VA, which allows for the procurement of the company's...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $62,000 delivery order to Recordati Rare Diseases, Inc. for pasireotide in various dosages under the firm fixed price Pharmaceuticals and Drugs Federal Supply Schedule contract. The order is for the supply of pasireotide 40 mg, 0.6 mg, and 0.9 mg products, with performance at a location in Bartlett, Tennessee. No set-aside provisions were applied to this award made to Recordati...